Free Trial

Ossiam Acquires 10,871 Shares of Centene Co. (NYSE:CNC)

Centene logo with Medical background

Ossiam increased its stake in shares of Centene Co. (NYSE:CNC - Free Report) by 95.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,292 shares of the company's stock after acquiring an additional 10,871 shares during the quarter. Ossiam's holdings in Centene were worth $1,350,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of CNC. Capital Advisors Ltd. LLC increased its stake in shares of Centene by 75.3% in the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after buying an additional 177 shares during the period. Hurley Capital LLC bought a new position in shares of Centene during the fourth quarter valued at about $26,000. Rialto Wealth Management LLC purchased a new stake in shares of Centene during the fourth quarter worth about $30,000. OFI Invest Asset Management purchased a new position in Centene during the 4th quarter valued at about $33,000. Finally, SRS Capital Advisors Inc. raised its position in Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock valued at $38,000 after purchasing an additional 267 shares during the last quarter. Institutional investors own 93.63% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Robert W. Baird reduced their target price on Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Wells Fargo & Company reduced their price objective on shares of Centene from $76.00 to $72.00 and set an "overweight" rating on the stock in a research report on Friday, February 14th. Guggenheim assumed coverage on shares of Centene in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Argus downgraded shares of Centene from a "buy" rating to a "hold" rating in a research note on Thursday, February 6th. Finally, StockNews.com raised Centene from a "buy" rating to a "strong-buy" rating in a research report on Friday, April 11th. Seven equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $80.69.

Get Our Latest Report on Centene

Centene Stock Down 6.2 %

CNC stock traded down $3.84 on Friday, reaching $57.74. 8,848,331 shares of the company traded hands, compared to its average volume of 4,746,772. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The firm has a fifty day simple moving average of $60.10 and a 200-day simple moving average of $60.97. Centene Co. has a one year low of $55.03 and a one year high of $80.59. The company has a market cap of $28.64 billion, a P/E ratio of 9.25, a price-to-earnings-growth ratio of 0.80 and a beta of 0.53.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $2.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.20 by $0.70. The company had revenue of $46.62 billion for the quarter, compared to analysts' expectations of $43.16 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. During the same quarter in the previous year, the business posted $2.26 EPS. Research analysts anticipate that Centene Co. will post 6.86 earnings per share for the current year.

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines